Introduction: One of the most pressing goals for cancer immunotherapy at this time is the
identification of actionable antigens. Methods: This study relies on the following …

With lung cancer remaining a challenging disease, new approaches to biomarker discovery
and therapy development are needed. Recent immunogenomics, adaptive immune receptor …

With the advent of large collections of adaptive immune receptor recombination reads
representing cancer, there is the opportunity to further investigate the adaptive immune …

With the improvement of treatment options, multiple myeloma related life expectancy has
been prolonged, but the disease remains largely incurable. Immunotherapy is a growing …

The liver is a site of immune privilege, compared with the bladder and skin, for example. To
study this attenuation of the immune response in the cancer setting, we compared quantities …

Simple Summary The chemical complementarity of glioblastoma, tumor-resident T-cell
receptors and cancer testis antigens were associated with a worse outcome. Additionally …

To better understand how adaptive immune receptors (IRs) in hepatocellular carcinoma
(HCC) microenvironments are related to disease outcomes, we employed a chemical …

T-lymphocytes have been implicated in facilitating a pro-inflammatory, pro-tumorigenic
microenvironment that worsens prognosis for esophageal carcinoma (ESCA). In this study …

The association between pancreatic adenocarcinoma (PAAD) and the pancreatic
microbiome is not fully understood, although bacteria may decrease the effectiveness of …

Cytomegalovirus (CMV) infection has been associated with poorer cognitive abilities, and
there has recently been an association of T cell receptor alpha (TRA) complementarity …